Retracted: Prognostic Value of Lactate Dehydrogenase, Melanoma Inhibitory Protein, and S-100B Protein in Patients with Malignant Melanoma

Detalles Bibliográficos
Autor principal: and Alternative Medicine, Evidence-Based Complementary
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2023
Materias:
Retraction
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10567369/
https://www.ncbi.nlm.nih.gov/pubmed/37829638
http://dx.doi.org/10.1155/2023/9846920
_version_ 1785119111937785856
author and Alternative Medicine, Evidence-Based Complementary
author_facet and Alternative Medicine, Evidence-Based Complementary
author_sort and Alternative Medicine, Evidence-Based Complementary
collection PubMed
description
format Online
Article
Text
id pubmed-10567369
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-105673692023-10-12 Retracted: Prognostic Value of Lactate Dehydrogenase, Melanoma Inhibitory Protein, and S-100B Protein in Patients with Malignant Melanoma and Alternative Medicine, Evidence-Based Complementary Evid Based Complement Alternat Med Retraction Hindawi 2023-10-04 /pmc/articles/PMC10567369/ /pubmed/37829638 http://dx.doi.org/10.1155/2023/9846920 Text en Copyright © 2023 Evidence-Based Complementary and Alternative Medicine. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Retraction
and Alternative Medicine, Evidence-Based Complementary
Retracted: Prognostic Value of Lactate Dehydrogenase, Melanoma Inhibitory Protein, and S-100B Protein in Patients with Malignant Melanoma
title Retracted: Prognostic Value of Lactate Dehydrogenase, Melanoma Inhibitory Protein, and S-100B Protein in Patients with Malignant Melanoma
title_full Retracted: Prognostic Value of Lactate Dehydrogenase, Melanoma Inhibitory Protein, and S-100B Protein in Patients with Malignant Melanoma
title_fullStr Retracted: Prognostic Value of Lactate Dehydrogenase, Melanoma Inhibitory Protein, and S-100B Protein in Patients with Malignant Melanoma
title_full_unstemmed Retracted: Prognostic Value of Lactate Dehydrogenase, Melanoma Inhibitory Protein, and S-100B Protein in Patients with Malignant Melanoma
title_short Retracted: Prognostic Value of Lactate Dehydrogenase, Melanoma Inhibitory Protein, and S-100B Protein in Patients with Malignant Melanoma
title_sort retracted: prognostic value of lactate dehydrogenase, melanoma inhibitory protein, and s-100b protein in patients with malignant melanoma
topic Retraction
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10567369/
https://www.ncbi.nlm.nih.gov/pubmed/37829638
http://dx.doi.org/10.1155/2023/9846920
work_keys_str_mv AT andalternativemedicineevidencebasedcomplementary retractedprognosticvalueoflactatedehydrogenasemelanomainhibitoryproteinands100bproteininpatientswithmalignantmelanoma

Ejemplares similares